Evidence map›Paper›PMID 42602920›Full record

ArticleCureus2026

Partial Anterior Cruciate Ligament (ACL) Tears in Adolescents: Are We Overtreating Them or Underestimating Who Should Not Wait?

Javier Gonzalez Almonacid

Abstract readEditorial
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Javier Gonzalez AlmonacidOrthopedics, San Borja Arriarán Clinical Hospital, Santiago, CHL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Partial anterior cruciate ligament (ACL) tears in adolescents remain clinically challenging because of their heterogeneous presentation and uncertain functional prognosis. Although traditionally considered less severe than complete ruptures, these injuries encompass a highly heterogeneous spectrum, ranging from functionally competent ligaments that maintain clinical stability and permit return to activity after rehabilitation to mechanically insufficient knees that rapidly progress to instability and secondary intra-articular damage. Accordingly, a major clinical challenge may lie not simply in choosing between surgery and nonoperative treatment, but in accurately identifying which adolescents are unlikely to succeed with conservative management. Available observational cohorts report progression to ACL insufficiency or delayed reconstruction in approximately 25%-39% of patients initially managed nonoperatively, although validated predictors of failure remain unavailable. The term partial ACL tear describes ligament morphology but does not necessarily reflect ligament function, because residual fibers may preserve sufficient biomechanical stability despite structural disruption, whereas some morphologically partial tears remain mechanically insufficient. Formal clinical prediction tools have not been adequately evaluated or externally validated, and existing studies have assessed individual clinical and imaging variables in small, heterogeneous cohorts with inconsistent findings. Therefore, treatment decisions should rely on comprehensive functional assessment, skeletal maturity, sporting demands, and the risk of secondary injury rather than MRI appearance alone. Reframing the debate in this way may improve patient selection and optimize treatment decisions for this complex injury.

Indexed as

adolescentanterior cruciate ligamentnonoperative treatmentpartial acl tearpediatric sport medicine

Identifiers

PMID42602920
PMCPMC13475473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.